.png "Janet Woodcock"){kind=small}
Robert Califf
Search results
Janet Woodcock (born August 29, 1948) is an American physician serving as Principal Deputy Commissioner of Food and Drugs, having previously served as Acting Commissioner of the U.S. Food and Drug Administration (FDA).
Feb 17, 2022 · Janet Woodcock is the FDA’s Principal Deputy Commissioner. In this role she works closely with the Commissioner of Food and Drugs to develop and implement key public health initiatives...
- Principal Deputy Commissioner
- Office of The Commissioner
Nov 16, 2023 · U.S. Food and Drug Administration (FDA) Principal Deputy Commissioner Dr. Janet Woodcock, who led the regulator during the height of the COVID-19 pandemic as acting chief, plans to retire early...
This Wednesday will be Dr. Janet Woodcock’s last day at the US Food and Drug Administration (FDA), capping a remarkable 38-year career at the agency. She’s been called one of the most powerful and influential drug regulators worldwide.
Jan 30, 2024 · Janet Woodcock, the FDA's principal deputy commissioner, reflects on her more than 30 years at the agency and hints at what's next. She oversaw hundreds of drug reviews, faced Covid-19 challenges and a reorganization plan.
Nov 17, 2023 · The longtime regulator, who led the agency's drug evaluation center and Covid-19 response, plans to leave in early 2024, FDA Commissioner Califf announced. Woodcock is a legend in public health and has made enduring improvements in FDA operations, according to former and current officials.
Nov 16, 2023 · US Food and Drug Administration Deputy Commissioner Janet Woodcock will retire next year after nearly four decades at the regulator that were marked by controversy over support for unproven medications for rare, serious conditions. Woodcock confirmed the news in an email.
